Revised Abstract: """"""""Biostatistics and Bladder Cancer Database"""""""", provides statistical input for the design, conduct, and interpretation of all laboratory and clinical studies as well as maintenance of the Bladder Cancer Research Database, a resource essential to the translational aspects of the program project. In the previous review, concerns were expressed about suboptimal integration of core biostatistical efforts with those of Project 2 and a lack of innovative statistical approaches to integrate biomarker results. The revised approach shows better integration of Core B activities with the plan for the statistical analyses of data to be collected for this project. It is clarified that Drs. Yu and Groshen have a longstanding collegial relationship and will be meeting regularly for discussions regarding implementation of the research, quality control, and the analytic plan. Methods for exploring the co-expression of COX-2 and DNMTs are elaborated with stratification for smoking status, vitamin C intake, and other variables. Power calculations have been revised to include two-tailed tests of significance, and samples sizes appear sufficient to detect approximate 10 percent differences with sufficient statistical power. Sample size considerations are given in greater detail for not only the univariate comparisons, but also for examination of two-way and three-way interactions. There is also a plan to incorporate multivariate modeling of the data for tumor stage at detection to evaluation impact of the biomarkers on progression of bladder carcinogenesis. Dr. Groshen has proposed to use resampling methods (Westiall and Young, 1993) to address overfitting issues in model selection. Data base activities of the core have been enhanced to include the management of specimen tracking and management of intermediate data. In summary, all of the issues raised in the previous review have been adequately addressed. As a result, Core B is now well-integrated with other components of the program project and provides excellent statistical support crucial to the success of this program. This core was previously rated as satisfactory and is now rated as superior.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA086871-01A2
Application #
6691381
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-09-13
Project End
2007-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Bartsch Jr, Georg; Mitra, Anirban P; Mitra, Sheetal A et al. (2016) Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder. J Urol 195:493-8
Catsburg, Chelsea E; Gago-Dominguez, Manuela; Yuan, Jian-Min et al. (2014) Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. Int J Cancer 134:125-35
Figueroa, Jonine D; Ye, Yuanqing; Siddiq, Afshan et al. (2014) Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet 23:1387-98
Figueroa, Jonine D; Han, Summer S; Garcia-Closas, Montserrat et al. (2014) Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis 35:1737-44
Fu, Yi-Ping; Kohaar, Indu; Moore, Lee E et al. (2014) The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res 74:5808-18
Corral, Roman; Lewinger, Juan Pablo; Van Den Berg, David et al. (2014) Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai. Int J Cancer 135:335-47
Mitra, Anirban P; Castelao, Jose E; Hawes, Debra et al. (2013) Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program. Cancer 119:756-65
Mitra, Anirban P; Hansel, Donna E; Cote, Richard J (2012) Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Semin Oncol 39:524-33
Davis-Dao, Carol A; Henderson, Katherine D; Sullivan-Halley, Jane et al. (2011) Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Cancer Epidemiol Biomarkers Prev 20:1156-70
Birkhahn, Marc; Penson, David F; Cai, Jie et al. (2011) Long-term outcome in patients with a Gleason score ýýý 6 prostate cancer treated by radical prostatectomy. BJU Int 108:660-4

Showing the most recent 10 out of 33 publications